Delivery Order SPE2DB25D3110-SPE2DB25FTDTY
Award Date 7/9/25
Potential Completion Date 7/10/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,620.17, is for the supply of Vraylar 4.5 mg capsules. The contract is a firm fixed-price delivery order and has an ultimate completion date of April 10, 2025. It is not associated with any set-aside requirements. The contract is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 4.5 mg capsules, a medication used to treat certain mental health conditions. The contract has a ceiling value of $8,247.22 and a period of performance ending on June 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Vraylar 4.5 mg capsules. The contract has a firm fixed price of $2,753.44 and an ultimate completion date of August 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $23,475.99 contract is for the supply of Vraylar 1.5 mg capsules, a specialty medication. The order has an ultimate completion date of October 16, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,858.07 firm fixed-price contract is for the supply of Vraylar 4.5 mg capsules. The contract has an ultimate completion date of October 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $2,656.83 and has an ultimate completion date of March 26, 2024. It is not designated as a set-aside contract. The contract provides for the delivery of Vraylar 6 mg capsules, a prescription medication used to treat certain mental health conditions. As an Indefinite Delivery Contract (IDC) holder with the...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,253.60, is for the delivery of Vraylar 1.5 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 2, 2025. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,188.07 firm-fixed-price contract is for the delivery of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $22,389.89 fixed-price contract is for the delivery of Vraylar 3 mg capsules, a medication used to treat certain mental health conditions. The contract has an ultimate completion date of May 2, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,844,508 units of the prescription drug Vraylar 1.5 mg capsules. The contract has a firm fixed price of $36,930.22 and a completion date of September 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999, for...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTDTYDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 4.5 mg capsules, a medication used to treat certain mental health conditions. The contract has a firm fixed price of $1,015.78 and a completion date of July 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. The contract is not designated as a set-aside.
Generated 10/8/25, 10:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/9/25 |